Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;5(2):e96-e106.
doi: 10.1016/S2352-3018(17)30209-6. Epub 2017 Nov 27.

Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study

Affiliations

Predictors of linkage to HIV care and viral suppression after release from jails and prisons: a retrospective cohort study

Kelsey B Loeliger et al. Lancet HIV. 2018 Feb.

Abstract

Background: Incarceration provides an opportunity for engagement in HIV care but is associated with poor HIV treatment outcomes after release. We aimed to assess post-release linkage to HIV care (LTC) and the effect of transitional case management services.

Methods: To create a retrospective cohort of all adults with HIV released from jails and prisons in Connecticut, USA (2007-14), we linked administrative custody and pharmacy databases with mandatory HIV/AIDS surveillance monitoring and case management data. We examined time to LTC (defined as first viral load measurement after release) and viral suppression at LTC. We used generalised estimating equations to show predictors of LTC within 14 days and 30 days of release.

Findings: Among 3302 incarceration periods for 1350 individuals between 2007 and 2014, 672 (21%) of 3181 periods had LTC within 14 days of release, 1042 (34%) of 3064 had LTC within 30 days of release, and 301 (29%) of 1042 had detectable viral loads at LTC. Factors positively associated with LTC within 14 days of release are intermediate (31-364 days) incarceration duration (adjusted odds ratio 1·52; 95% CI 1·19-1·95), and transitional case management (1·65; 1·36-1·99), receipt of antiretroviral therapy during incarceration (1·39; 1·11-1·74), and two or more medical comorbidities (1·86; 1·48-2·36). Reincarceration (0·70; 0·56-0·88) and conditional release (0·62; 0·50-0·78) were negatively associated with LTC within 14 days. Hispanic ethnicity, bonded release, and psychiatric comorbidity were also associated with LTC within 30 days but reincarceration was not.

Interpretation: LTC after release is suboptimal but improves when inmates' medical, psychiatric, and case management needs are identified and addressed before release. People who are rapidly cycling through jail facilities are particularly vulnerable to missed linkage opportunities. The use of integrated programmes to align justice and health-care goals has great potential to improve long-term HIV treatment outcomes.

Funding: US National Institutes of Health.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests

We declare that we have no conflicts of interest.

Figures

Figure 1
Figure 1. Consort Diagram
CTDOC: Connecticut Department of Correction; CTDPH: Connecticut Department of Public Health.
Figure 2
Figure 2
Time to linkage to care as measured by first HIV RNA viral load drawn after release from prison or jail

Comment in

References

    1. Glaze LE, Kaeble D. Bureau of Justice Statistics. U.S. Department of Justice - Office of Justice Programs; 2014. Correctional Populations in the United States, 2013. Accessed on March 10, 2017 at: https://www.bjs.gov/content/pub/pdf/cpus13.pdf.
    1. Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102. - PubMed
    1. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PloS one. 2009;4(11):e7558. - PMC - PubMed
    1. Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA internal medicine. 2014;174(5):721–9. - PMC - PubMed
    1. Milloy MJ, Montaner JS, Wood E. Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention. Current HIV/AIDS reports. 2014;11(3):308–16. - PMC - PubMed

Publication types

Substances